Related Experiment Video
Updated: Mar 6, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
RENAL FUNCTION MARKERS FOR LONG-TERM CARDIOVASCULAR PREDICTION IN INDIVIDUALS AFTER MYOCARDIAL REVASCULARIZATION
1Federal State Budget-Funded Educational Institution of Higher Education Rostov State Medical University at the Ministry of Health of the Russian Federation, Department of Internal Medicine N2, Russia.
Insights
Increased urinary albumin excretion after myocardial revascularization indicates higher cardiovascular risk. Left ventricular hypertrophy also significantly impacts long-term outcomes in patients with ischemic heart disease.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Cardiovascular complications are a major concern following myocardial revascularization.
- Renal dysfunction is an emerging risk factor for adverse outcomes in cardiac patients.
- Understanding the interplay between renal health and cardiac events post-revascularization is crucial.
Purpose of the Study:
- To assess the impact of renal dysfunction on long-term cardiovascular complications after myocardial revascularization.
- To identify specific renal markers predicting adverse events.
- To evaluate the role of traditional risk factors alongside renal markers.
Main Methods:
- Prospective study of 90 patients with ischemic heart disease undergoing myocardial revascularization (CABG or stenting).
- Assessment of renal dysfunction markers (albuminuria, β2-microglobulinuria) before and after revascularization.
- Coronary angiography to assess plaque progression; long-term follow-up for death or repeat revascularization.
Main Results:
- Increased urinary albumin excretion (Al) significantly correlated with adverse outcomes (p=0.04).
- Left ventricular hypertrophy indicators (interventricular septum and posterior wall thickness) significantly impacted mortality and revascularization needs (p<0.05).
- β2-microglobulin (β2-MG) showed a linear relationship with atherosclerosis progression (r=0.41, p=0.0008).
Conclusions:
- Dynamic assessment of urinary albumin excretion serves as a cardiovascular risk marker post-myocardial revascularization.
- β2-microglobulin levels correlate with the rate of atherosclerosis progression.
- Left ventricular hypertrophy is a significant predictor of long-term adverse events in this patient cohort.
Abstract:
Goal - assessment of the renal dysfunction impact on the probability of cardiovascular complications development in the long-term period after myocardial revascularization. 90 patients with ischemic heart disease (IHD) and myocardial revascularization indications were involved in the study. All the patients underwent coronary angiography (CAG), by determining the method of myocardial revascularization (MR) - coronary artery bypass grafting or coronary artery stenting. Traditional risk factors and renal dysfunction markers (albuminuria in the range of 30-300 mg/L, β2-microglobulinuria) were revealed in all the patients examined. Renal risk factors were examined twice - before myocardial revascularization and 6.3±0.1 months after it. According to CAG results, the endophytic growth rate of atheromatous plaque was determined by the calculation method. Death or need for repeated myocardial revascularization in 5.8±0.05 years was considered the endpoint of the study. Of the 81 patients who continued to participate in the study, 10 patients died (12.3%), 4 patients underwent MR (4.9%). Statistical analysis of the data showed that increase in Al semi-quantitative value (χ-test - 4.25; p=0.04) has a significant effect on the probability of reaching the endpoint of the study. A significant effect on the studied prognosis of β2-microglobulin (β2-MG) (>0.05) could not be established. However, a direct linear relationship between β2-MG value in urine and VEG AB (r=0.41, p=0.0008) was established. Among all the traditional risk factors studied, a significant impact of the left ventricle myocardial hypertrophy indicators on the death risk or repeated MR [thickness of interventricular septum (χ-test - 4.03; p=0.04) and left ventricular posterior wall (χ-test - 7 49; p=0.006)] was established. According to the results of the study, implementation of the cardiorenal syndrome in the form of a predictive Al value and β2-MG determination in urine, was shown. An increased urinary albumin excretion in dynamics is a cardiovascular risk marker in the long-term period after MR. β2-MG indicator has a direct linear relationship with the atherosclerosis progression rate. Among all the traditional risk factors, the left ventricular hypertrophy indicators have a particular importance.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Acute Kidney Injury IV: Diagnostic Studies and Prevention

